(OTC: MNCL) Is Finalizing Distribution Rights for the Treatment of Male Testosterone Deficiency
Friday, February 23, 2007 9:09 AM
Symbols: AMAT, CHTR
Martin Nutraceuticals Inc. (PINKSHEETS: MNCL) is finalizing an agreement for distribution rights for the treatment of male testosterone deficiency.

To read the complete release, go to http://biz.yahoo.com/bw/070222/20070222005973.html?.v=1

For a Free Newsletter, go to http://www.OTCReporter.com

Other active stocks are Applied Materials, Inc. (NASDAQ: AMAT), Charter Communications, Inc. (NASDAQ: CHTR) and Nitches, Inc. (NASDAQ: NICH).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A Third Party has hired and paid $500.00 for the publication and circulation of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation, do no trading of any kind and send No Faxes or Emails to promote stocks.

(Source: Market Wire )

More Options



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 300 contributors and press releases, SEC filings and full text news from thousands of sources.


 
Rate :  Rate this Commentary  


 Number of Comments (0) Post Comment
 
  
Good Rating(+1)    Bad Rating(-1)
No Data Found

 
Enter Symbol
Enter Search String
Bookmark This Article
Email Article

Send this article by email


Recipient's Name
Recipient's E-mail
Your Name
Your E-mail
Related Quotes

 
  Home | Login |Research | Earnings | Scans | Chat Rooms | Charts | Submit Article | Join Blog Network | Contributors | Subscribe to RSS

copryright 2008 all rights reserved